Impact of covid 19 on neurological manifestations in Fayoum University Hospitals. | ||
| Fayoum University Medical Journal | ||
| Articles in Press, Accepted Manuscript, Available Online from 22 May 2024 PDF (323.29 K) | ||
| Document Type: Review Articles | ||
| DOI: 10.21608/fumj.2024.259670.1302 | ||
| Authors | ||
| Fatma Elzahraa Osman Metwally* 1; Sayed Sobhy Sayed2; Asmaa Younis Elsary3; Mohamed El-Sayed Mohamed1 | ||
| 1Neurology | ||
| 2Neurology, Fayoum university, Fayoum | ||
| 3Community department, Fayoum university, Fayoum | ||
| Abstract | ||
| Background: The Chinese health officials kept an eye on a cluster of pneumonia cases that occurred in the Chinese city of Wuhan (Hubei, China) in December 2019. The novel coronavirus severe acute respiratory syndrome coronavirus-2 pathogen, often referred to as COVID-19, was the cause of this. Objectives: The goal of this review is to concentrate on the neurological manifestations of 2019 coronavirus disease and to describe the existing published data as well as ongoing trials. Methods: Scopus, PubMed, & the Cochrane Library were searched from their inceptions until May of 2020 for any published papers using the terms "COVID 19" and "neurological disorders." To make sure no other clinical trials were overlooked, a separate search of Google Scholar was also conducted. The author examined the list of references of the research that was cited or relevant reviews that were recognized through the trial in order to make sure that the literature was sufficiently covered. If there were many publications on the same clinical trial, the most recent and thorough report was the one that was chosen. Results: A search of all three databases yielded a total of 89 articles. Twenty-two full-text papers were reviewed for eligibility, and twelve were found to be ineligible. There were 290 patients reported to have neurological symptoms throughout all investigations. All central nervous system (CNS) signs, with the exception of headache, were more common in severe cases according to the COVID-19 severity classification. Adults only were participated in all of the included investigations. | ||
| Keywords | ||
| Key words: covid 19; stroke; insomnia; neurological manifestations | ||
|
Statistics Article View: 86 PDF Download: 111 |
||
